Some ketogenic diets found to cause mitochondrial stress and lead to inflammation
Results from UC Cancer Center research published in Science Advances
New University of Cincinnati Cancer Center research found a ketogenic diet high in long-chain saturated fatty acids can increase inflammation.
Led by Cancer Center Director David Gius, MD, PhD, the study was published Nov. 13 in the journal Science Advances.
What was the research methodology?
A ketogenic diet is high in fat and low in carbohydrates, with the goal of entering ketosis, a metabolic state where the body burns fat and ketones for fuel instead of glucose. While many previous studies have demonstrated anti-inflammatory benefits from a ketogenic diet, other studies have shown increased inflammation and other harmful effects. Gius and colleagues have identified a potential factor contributing to these divergent outcomes.
“We followed the research data while studying a different aspect of ketogenic diets and found something unexpected,” said Gius, who also serves as professor in the Department of Radiation Oncology in UC’s College of Medicine and is a UC Health physician. “Our previous studies have found that all ketogenic diets are not the same, with different fats causing different metabolic changes.”
In this study, Gius and his team administered ketogenic diets comprising different fatty acids to mice animal models and individual fatty acids to tissue culture models.
What were the results?
“We found that long-chain saturated fatty acids seem to favor an inflammatory immune response, whereas unsaturated and medium-chain fatty acids tend to favor anti-inflammatory characteristics.”
The findings demonstrate that the observed increase in inflammation is mediated through mitochondrial stress signaling and activation of immune cells. When these findings are combined with those in the team’s previous publications in Science Advances (2024) and Cell Reports (2025), it suggests that multiple factors may need to be considered to achieve the desired outcome on a ketogenic diet, including dietary sources of fat.
In the context of cancer, Gius said ketogenic diets may alter tumor microenvironments in a way that improves immunotherapy treatment outcomes. A clinical trial is underway at UT Health San Antonio, where Gius began the research, and will open soon at the Cancer Center to learn more.
The next groundbreaking discovery
UC is a powerhouse of discovery and impact as a Carnegie 1 research institution. From pioneering medical research to transformative engineering and social innovation, our faculty and students drive progress that reaches across the world.
Featured photo at top: David Gius, MD, PhD. Photo/Colleen Kelley/UC Foundation.
Related Stories
Cancer Center experts present at national conference
May 27, 2025
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology Annual Meeting May 30 to June 3 in Chicago.
Understanding resistance to targeted therapies in head and neck, breast cancer
July 11, 2025
MSN highlighted University of Cincinnati Cancer Center and Cincinnati Veterans Affairs Medical Center research published in the journal Oncotarget that reviewed current research on why Epidermal Growth Factor Receptor-targeted therapies often fail in breast and head and neck cancers.
UC Cancer Center, Varian complete Flash radiotherapy trial enrollment
August 26, 2025
Yahoo Finance highlighted Varian's announcement of the successful completion of enrollment and treatment in the FAST-02 clinical trial targeting painful bone metastases in the thoracic region at the University of Cincinnati Cancer Center.